Table of Content


1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Cardiovascular Surgical Devices Market



6. Market Share
6.1 By Product Type
6.2 By Application
6.3 By End User
6.4 By Countries


7. Product Type
7.1 Beating Heart Surgery Systems
7.2 Cardiopulmonary Bypass Equipment
7.3 Cardiac Ablation Devices
7.4 Perfusion Disposable


8. Application
8.1 Congential Heart Defects
8.2 Cardiac Arrthymia
8.3 Coronary Heart Disease
8.4 Congestive Heart Failure
8.5 Others


9. End User
9.1 Hospitals
9.2 Ambulatory Surgical Centers
9.3 Others


10. Countries
10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherland
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue Analysis

13.2 Boston Scientific Corporation
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue Analysis

13.3 Edwards Lifesciences
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue Analysis

13.4 Cardinal Health Inc.
13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue Analysis

13.5 Medtronic PLC
13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue Analysis

13.6 GE Healthcare
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue Analysis

13.7 LivaNova PLC
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue Analysis

13.8 Terumo Corporation
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue Analysis



List of Figures


0

List of Tables


0